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Although a considerable body of evidence has implicated the Group A strepto- 
coccus in the pathogenesis of rheumatic fever, the exact role the organism plays 
in  the  initiation  of the  pathological  process  still  remains  unclear.  Among 
various hypotheses entertained has been the concept that the Group A strepto- 
coccus, through its long association with its human host, has acquired antigens 
which cross-react with mammalian tissues. During the infection with the orga- 
nism, the rheumatic susceptible individual may produce an unusual immune 
response to streptococcal antigens eliciting antibodies which bind to host tis- 
sues. This concept has been strengthened by the finding in many laboratories 
that Group A streptococci contain antigens which cross-react with a variety of 
mammalian  tissues including cardiac and skeletal muscles (1-4), valvular tissue 
(5, 6), kidney (7), skin, and even certain neuronal tissues (8). Antibodies which 
bind to heart and skeletal tissue have also been found in the sera of acute 
rheumatic individuals, correlate well with clinical parameters of the disease, 
and are invariably seen with recurrences (9). The streptococcal nature of heart- 
reactive antibodies in acute rheumatic fever has been established by the absorp- 
tion of these antibodies with streptococcal antigens (1, 9). 
Despite these findings, it has been difficult to reconcile the presence of these 
tissue-reactive antibodies with one of the most striking clinical forms of acute 
rheumatic activity -  namely, the occurrence  of Sydenham's  chorea. The clinical 
manifestations of this form of rheumatic fever are presumed to be associated 
with an inflammatory process or physiologic dysfunction of the brain (10, 11) 
and  are  oi~en  seen without any other evidence of rheumatic activity,  i.e., 
carditis or arthritis. 
Among the possibilities entertained to explain this unusual form of rheumatic 
activity is the concept that patients with chorea possess circulating antibodies 
directed against components of the central nervous system. The observation 
that a  considerable proportion of children seen at the Free Rheumatic and 
Heart Center, Giza,  Egypt, present primarily with recurrent bouts of chorea 
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without the classical manifestations of arthritis and carditis offered us a unique 
opportunity to test this hypothesis. The present study provides evidence for the 
presence of antibodies to neuronal tissues. The streptococcal-induced nature of 
these antibodies was established by the fact that absorptions only with Group A 
streptococcal  membranes  abolish  the  immunofluorescent-staining  pattern  in 
neuronal cells.  The tissue-specific staining pattern was evidenced by the fact 
that only isolated neurons abolished the immunofluorescent staining pattern. 
Moreover, serial studies of sera in a number of patients with chorea appeared to 
indicate that the presence of these antibodies correlates with the clinical course 
of disease. A preliminary report of these findings has recently been presented 
(12). 
Materials and Methods 
Clinical Material 
RHEUMATIC FEVER PATIENTS.  A group of 80 children with acute rheumatic fever including 77 
patients seen at the Free Rheumatic and Heart Center were studied.  In addition three patients 
from Port of Spain, Trinidad, with acute rheumatic activity were also included in the group. The 
diagnosis of acute rheumatic  fever was made on the basis  of the American Heart Association 
Modified Jones Criteria (13). 30 children (ages 6-14 yr) had rheumatic chorea and many of these 
patients had recurrent bouts of the disease. In addition a number of these patients had clear-cut 
physical findings  of mitral  stenosis  and]or  mitral  regurgitation  at the time of the study.  An 
additional  group of 50 other children,  ages 6-13 yr had  primarily active carditis and  arthritis 
without  choreiform  manifestations.  While  the  majority  of  these  patients  were  receiving 
salicylates, three patients had received corticosteroids (5-15 mg of prednieone/day). 
For the serial examination of the presence of neuronal antibodies, the sera from six patients 
with well-documented rheumatic chorea were selected from the serum banks of the Rheumatic 
Fever Service of The Rockefeller University Hospital, New York. In addition serial sera from four 
Egyptian patients and one patient from Trinidad were available for study. 
CONTROLS.  A wide variety of control sera were employed in these studies. They were selected 
from the following groups of individuals: 
(a) 71 normal Egyptian and American subjects ranging in ages between 6 and 45 yr. (b) 19 acute 
poststreptecoccal glomerulonephritic sera, kindly supplied by Dr. E. Potter, Northwestern Uni- 
versity School  of Medicine,  Chicago,  Ill.  (c)  Eight  sera  obtained  from  individuals  who  had 
uncomplicated  streptococcal  pharyngitis.  The  sera  from  groups  2  and  3  had  anti-streptelysin 
(ASO)  ~ titers greater than 250 Todd units.  (d) 65 sera obtained from patients with systemic lupus 
erythematosus and rheumatoid arthritis.  (e) 75 sera from a miscellaneous group of patients with 
neoplasms, bacterial infections, chronic obstructive lung disease, cirrhosis, and diverse neurologi- 
cal states (i.e. strokes, multiple sclerosis, Parkinson's disease, cerebral atrophy, paresis, periph- 
eral neuropathy,  and amyotrophic lateral sclerosis). 
All sera to be studied were kept frozen at -20°C until use. Immediately before testing, the sera 
were heat inactivated at 56°C for 30 min. Sera from the serum bank at The Rockefeller University 
had never been frozen but had been stored sterilely at 4°C for periods of up to 30 yr. 
ImmunofluorescenceStudies.  Because of  the probable localization of functional derangement in 
chorea to the areas which include the subthalamic and caudate nuclei (10, 11) particular care was 
taken in the selection of the tissues. Accordingly, fresh human brain was obtained from a 45-yr old 
previously healthy man within 4 h of death in a traffic accident. Specimens from caudate nucleus, 
subthalamic nucleus, cerebral cortex, and cross sections of medulla containing trigeminal nuclei, 
geniculate ganglion, and hypoglossal nuclei were dissected from fresh brain, cut into small pieces 
(3 x 3 x 5 mm), immediately embedded in OCT (Ames Co., Div. of Miles Lab. Inc., Elkhart, Ind.), 
and snap-frozen in dry ice/acetone. Unfixed frozen sections (4-6 pm) served as substrate for brain 
antigens. For screening, the sections were incubated with undiluted test sera for 30 rain in a moist 
1 Abbreviations used in this paper: ANA, anti-nuclear antibodies; ASO, anti-streptolysin; DTT, 
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chamber,  rinsed twice in phosphate-buffered  saline  (PBS),  pH  7.4,  for 10 min  and thereaiter 
overlaid with fiuorescein isothiocyanate (FITC)-conjugated pepsin-digested rabbit IgG antibodies 
to F(ab')2 fragments of human IgG (14), washed, and mounted in PBS/glycerol. Stained sections 
were then examined by immunofluorescence microscopy, using a  Zeiss fluorescence microscope 
with a mercury HBO 200 W lamp with BG12 primary filter, 53 Barrier filter and the Zeiss F.I.T.C. 
filter (Carl Zeiss, Inc., New York). Twofold titrations of positive sera were also performed. 
To determine the immunoglobulin (Ig) class of the serum antibodies, FITC-conjugated antisera 
specific for a-, 7-, or ~-chains were used as the second layer in the indirect immunofluorescence 
test. Specificity of fluorescence was checked by using absorption of specific antisera with respec- 
tive antigens,  as well as by preincubation of the sections with unconjugated antisera. 
All sera were also tested for anti-nuclear antibodies  (ANA) by indirect immunofluorescence 
using unfixed frozen sections from human kidney and mouse liver as substrate for antigen (15). 
The sera were tested both undiluted and at a dilution of 1:10. 
Absorption Experiments.  When positive staining was recorded, the following absorption ex- 
periments were carried out.  1 mg of the antigen to be tested was incubated with  1 ml of both 
positive and negative sera. Group A streptococcal antigens included Type 6 protoplast membranes, 
cell walls,  and  Group  A  polysaccharide.  A  further  test  of specificity included  absorptions  of 
rheumatic fever sera with cell walls and membranes from unrelated bacteria (Group D streptococ- 
cus) as well as separate absorptions with human  Cohn Fraction IV (Pentex Biochemical, Kan- 
kakee,  Ill.). Initially, absorptions  employed 1 mg of absorbing antigen/ml of human  serum.  In 
several  instances,  parallel  absorptions  using  membranes  from  Group  A  as  well as  Group  D 
streptococci were performed using a range of 1.0-0.001 mg/ml of serum. 
In  order  to  identify  what  central  nervous  system  structures  were  involved with  positive 
immunofluorescent staining, parallel sections from the same tissue blocks were fixed in formalin 
and stained with hematoxylin and eosin. In many instances when positive neuronal immunofluo- 
rescence was recorded, localization to neurons could be confirmed directly under UV fluorescence 
by identification of yellow granules of autofluorescence representing lipofuchsin in tl~e cytoplasm 
of positively staining nerve cells. In order to rule out possible specificity for antigens present in the 
first brain studied, similar sections from fresh brain of five other individuals were also examined. 
Streptococcal Strains.  The streptococcal strains used in these studies were all obtained from 
The Rockefeller University Rheumatic Fever Service collection. These included S 43/100/2  (M-type 
6), T 12/126/2  (M-type 12), D 678 (M-type 11), and A 928 and A 995 (types 55 and 57, respectively). 
As a control, a Group D streptococcal strain, A 932, was also used. 
Preparation of Streptococcal Antigens.  All organisms were grown in filter-sterilized dialyzed 
Tedd-Hewitt broth  (Difeo Laboratories,  Detroit,  Mich.  prepared  in  20-liter carboys  as follows: 
Todd-Hewitt (600 g) and yeast extract (Difco Laboratories) (60 g) were resuspended in 500 ml dis- 
tilled water using heat. Antifoam (Dow Chemical, Midland, Mich.) was added to prevent exces- 
sive foaming.  The solubilized media was then placed in dialysis tubing  (Fisher Scientific Co., 
Pittsburgh, Pa.) and dialyzed against two changes of 10 liters of distilled water. The dialysate was 
finally sterilely filtered into a  carboy using a  Coors no.  2 candle (Coors Porcelain Co., Golden, 
Colo.).  The carboys were then inoculated with 250  ml of a  culture in the logarithmic phase of 
growth. Aider incubation at 37°C for 18 h, the cultures were harvested using a Sharpies high speed 
centrifuge (Sharpies-Stokes Div., Pennwalt Corp.,  Warminster,  Pa.)  and frozen at  -70°C until 
processed further. 
For the preparation of protoplast membranes, phage-associated lysin was prepared and purified 
through cellulose phosphate chromatography  according to the procedure of Fischetti et al.  (16). 
Group A  streptococcal membranes were prepared  using the purified Group C  phage-associated 
lysin as described by Zabriskie and Freimer (4) with slight modification as follows: After thawing, 
the organisms were washed with saline and then resuspended in 0.06 M sodium phosphate buffer 
(pH 6.1) containing 4% sodium chloride and 5 × 10 `4 ~l dithiothreitol (DTT) (10 volumes buffer per 
gram wet weight of organisms). To this was added DTT-reactivated lysin (10,000 U lysin per gram 
wet weight of cells) and 5 mg of DNase (Sigma Chemical Co., St. Louis, Mo.). The mixture was 
incubated  at 37°C for 2 h  and monitored for protoplast  formation by dark-field microscopy and 
Gram stain. After what appeared to be 100% conversion of intact streptococci to protoplasts,  the 
suspension  was  incubated  for  an  additional  30  min.  The  remainder  of the  treatments  and 
procedures  followed those  of Zabriskie  and  Freimer  (4)  using  10 volumes buffer per gram wet 
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Group  A  and  Group  D  cell walls  and  Group  D  membranes  were prepared  as  follows:  the 
organisms were thawed and washed two times in 0.01 M PBS, pH 7.6,  and finally resuspended in 
distilled water. Cells were then fragmented in a Vibrogen cell mill (Rho Scientific Co., Commack, 
N. Y.) and assayed for breakage using the Gram stain. The glass beads were removed by filtration 
and cell walls were collected by centrifugatien at 12,000 g  for 60 rain. The supernate was centri- 
fuged further at 100,000g for 1 h in a Beckman Model L-1 ultracentrifuge (Beckman Instruments, 
Inc., Fullerton, Calif.). The pellet contained the cell membrane fraction. Both the cell wall and 
membrane fractious were washed three times with PBS and finally treated with DNase and RNase 
(Sigma Chemical Co.) for 2 h  at 37°C.  Atter extensive washings with PBS and i'mally distilled 
water, the fractious were lyophilized. Each fraction served as a test material for the absorptions. 
Tissue Antigens. 
SA~COL~MMA.  Fresh human  heart  tissue  (10  g) was  homogenized in a  Sorvall Omnimixer 
(DuPont Instruments, Sorvall Operations, Newtown, Conn.) in the presence of  distilled water for 5 
rain at 4°C. The thick slurry was centrifuged at 14,000g for 30 rain, and the pellet which contained 
the sarcolemmal sheaths was then washed three times in saline. Next, sarcolemma sheaths were 
allowed to autolyze in a 100-fold  (wt/vol) excess of distilled water for 24 h at 4°C. The sheaths were 
then centrifuged at 14,000g for 30 min. This process was repeated three times. The sheaths were 
then treated with DNase and RNase at 37°C for 3 h  and subsequently washed three times with 
distilled water and lyophilized. Under light microscopy, a negligible number of Z bands remained, 
indicating a loss of intracellular contents. This sarcolemmal sheath preparation served as a source 
of the insoluble antigenic matrix. 
BRAIN.  Finely  chopped  caudate  nucleus  from  fresh  normal  human  brain  was  utilized  to 
prepare  nerve cell bodies using  the method  described by Sellinger et al.  (17),  which  employs 
differential centrifugation through sucrose-bovine serum albumin gradients.  Fractions contain- 
ing neuron cell bodies showed 85-90% neuronal perikarya and were used to absorb sera positive for 
anti-neuronal antibody. 
LIw.a.  Human and mouse liver tissue extracts were prepared by freezing and thawing tissues 
five times followed by homogenization at high speed in a  Sorvall Omnimixer (DuPont Instru- 
ments,  Sorvall  Operations)  with  an  equal  volume of PBS.  The  liver suspensions  were  then 
sonicated six times for 30 s in a Bronson sonifier (Brouson Instruments, Inc., Stamford, Conn.) and 
after centrifugation at 18,000 g  for 30 rain, the supernates as well as tissue pellets were used in 
absorption studies at a concentration of 1 mg/ml. 
Results 
Immunofluorescent Staining.  When  sera  from a  number of patients  with 
chronic recurrent chorea were layered over sections of brain tissue and counter- 
stained with fluoresceinated anti-human gamma globulin, a striking pattern of 
immunofluorescence was seen. The type of fluorescence is illustrated in Figs. 
1 A and 1 B where large, bright areas of immunofluorescence are seen through- 
out the section. Comparison with companion hematoxylin eosin sections of the 
same  area  (Fig.  1 C) revealed that  the  staining  pattern  was localized in  the 
cytoplasm of the neuronal  cells of the caudate and subthalamic nuclei.  In all 
cases the positive-staining patterns were localized to the cytoplasm of moder- 
ately large neurons.  No nuclear membrane  or nuclear staining  was noted in 
these preparations.  Fig. 1 D demonstrates that when normal sera were applied 
to the section, no specific fluorescence was seen. The smaller dots of fluorescence 
(see arrows) were lipofuchsin granules which exhibited yellow or orange auto- 
fluorescence present in normal brain sections. 
In all instances, immune fluorescent staining was identified as the IgG class of 
immunoglobulin  using  H-chain-specific antisera.  No staining  for IgA or IgM 
was recorded.  In order to rule out possible nonspecific IgG binding of chorea 
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FIO. 1  A  and B. Immunofluorescent photomicrographs of  frozen  sections  of  normal human 
brain 'caudate nucleus'  showing positive  staining  reactions  with cytoplasm of  moderately 
large neurons using serum from a child  with prolonged active  chorea. Reference arrows 
indicate  nonspecific  yellow autofluorescence produced by lipofuchsin  granules in neurons 
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FIG. 1  C.  Hematoxylin and  eosin  section  of  normal  caudate  nucleus  used  as  substrate  for 
immunofluorescence testing  showing relative  size  and density  of  neurons in this  area. x 
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Fro.  1 D.  Control section treated with normal serum  showing background autofluores- 
cence of lipofuchsin granules,  x  500. 
tissue,  IgG was isolated from positive sera,  pepsin digested,  and F(ab')2 frag- 
ments applied to test frozen sections. Application of fluorescein-labeled F(ab')2 
anti-F(ab')2 confirmed specific binding of pepsin-digested antibody to neuronal 
cytoplasm. 
Localization and Staining Patterns.  Table I summarizes the results of nine 
chorea  patients  who exhibited  positive  immunofluorescent  staining  patterns. 
Using sections of caudate nucleus,  subthalamic  nucleus,  cerebral cortex,  and 
medullary nuclei,  it can be seen that  9 of 22  sera from children  with chorea 
showed concordant staining of neurons in both caudate and subthalamic nuclei. 
Two of  the latter showed stronger staining (+ +) in caudate than in subthalamic 
(+)  sections.  Three  sera  also  showed weak  (_+) staining  of neuronal  cells  in 
cerebral cortex and five showed positive staining (_+  -  +) of neurons in medul- 
lary nuclei. The staining intensity and numbers of cells staining were consider- 
ably greater in both caudate and subthalamic nuclei than in sections of cerebral 
cortex.  Concomitant titrations  for intensity of staining  in caudate and medul- 
lary nuclei showed essentially similar titers in three sera, 286, 274, and 230; and 
lower  titers  using  medullary  nuclei  in  two,  8008  and  4162.  No  concomitant 
staining for nerve cell nuclei was recorded.  By contrast, only 7 of 50 sera from 
children  with  rheumatic  carditis  showed  caudate  and  subthalamic  neuronal 
staining.  Four of these seven showed concomitant medullary nuclei nerve cell 
staining.  Higher  titers  of antibody  reacting  with  caudate  and  subthalamic 
neurons  (mean titer 5.7) were recorded in sera from children with chorea than 
were detected in the seven patients with carditis  (mean titer 2.1). 
A  general summary of results recorded with the entire group of 80 sera from 
patients  with  acute rheumatic  fever,  as well as the various control groups is 
shown in Table II. The differences between the prevalence of positive reactions 
in chorea and carditis sera and normal controls was significant (P <  0.005 andP 
<  0.05). In general, control sera showed negative reactions. 1 of 31 normal adult 
sera showed a  weak  (_+) reaction  and  none of 24 normal  children's  sera were 1102  ANTI=NEURONAL  ANTIBODY  IN CHOREA 
TABLE I 
Relative  Immunofluorescence Reactions  of  Sera  from Patients  with  Rheumatic Chorea 
and Rheumatic Carditis 
Sub-  Medullary nuclei Cerebral  Patient  Age  Sex  Caudate nucleus  thalamic  ANA 
no.  (tiber)  (titer)  cortex 
nucleus 
yr 
Chorea 
286  11  F  +  (8)  +  +  (4)  -  0 
303  10  F  +  (8)  +  0 -  0  0 
229  12  F  +  (2)  +  0  -  0  0 
284  9  F  +  (2)  +  0 -  0  0 
8088  11  M  +  (8)  +  ±  (undiluted)  +-  0 
274  9  F  ++  (16)  +  +  (16)  _+  0 
272  8  M  +  (2)  +  0 -  0  0 
230  9  M  ++  (4)  +  +  (4)  0  0 
4162  9  F  +  (2)  +  +  (undiluted)  0  0 
5.7 mean titer 
Carditis 
4460  13  M  +  (2)  +  +  0  0 
228  13  F  +  (4)  +  0  0  0 
245  13  F  +  (4)  +  0  0  0 
5116  10  M  +  (undiluted)  +  0  0  0 
4154  11  F  +  (undiluted)  +  +  (undiluted)  0  0 
4145  5  M  +  (undiluted)  +  _+ (undiluted)  0  0 
4006  13  F  +  (2)  +  +  (undiluted)  0  0 
2.1 mean titer 
positive. None of eight sera obtained from patients with uncomplicated  strepto- 
coccal pharyngitis  were positive, and  1  of 19  sera obtained from patients  with 
acute poststreptococcal glomerulonephritis ~vas positive. The small proportion of 
positive  sera  observed  in  patients  with  systemic  lupus  erythematosus  and 
juvenile  rheumatoid  arthritis  were  weakly  positive only in  undiluted  serum. 
Patients  with other diverse destructive or degenerative  neurological conditions 
including Parkinson's  disease, cerebrovascular  accidents, and amyotrophic lat- 
eral sclerosis were uniformly negative. 
Further  analysis  of clinical  records  among  chorea  patients  revealed  that 
patients with the most severe and prolonged bouts of chorea were most likely to 
show positive neuronal  immunofluorescence. Thus patients 274 and 230 in Table 
I  had  shown  multiple  severe  attacks  lasting  6-12  mo  in  both  instances.  In 
addition  the  appearance  of the  antibody  appeared  to  be  correlated  with  the 
duration of chorea, thus only one of eight patients with chorea of 2 mo or less had 
detectable antibodies while three of three patients who had chorea continuously 
for 6  mo or longer had positive tests for anti-neuronal  staining.  Finally, it was 
also noted that there appeared to be a  relationship  between the general clinical 
severity of chorea and the presence of positive staining  as well as the titer of 
anti-neuronal  antibodies (Table III). 
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TABLE II 
Prevalence of Antibodies Reacting with Caudate and Subthalamic Nuclei in 
Comparative Groups of Normals and Patients Studied 
No. positive/no.  Group studied  studied 
Normal controls 
Children 
Adults 
Streptococcal  patients 
Rheumatic carditis 
Rheumatic chorea 
Poststreptococcal  glomerulonephritis 
Streptococcal  pharyngitis 
Nonstreptococcal disease 
Connective tissue  disease 
Systemic lupus erythematosus  2/27* 
Adult rheumatoid arthritis  0/10 
Juvenile rheumatoid arthritis  2/28* 
Neurological disease 
Multiple sclerosis  0/21 
Strokes, Parkinson's disease,  amyotrophic  0/15 
lateral  sclerosis,  peripheral neuropathy 
Miscellaneous diseases 
Pneumonia, Hodgkin's disease,  cirrhosis,  1/20" 
myocardial infarctions 
% 
0/24*  (0) 
1/31  (3.2) 
7/50  (14.0) 
14/30  (46.6) 
1/19"  (5.2) 
O/8  (0) 
(7.4) 
(0) 
(7.1) 
(0) 
(0) 
(5.0) 
[P <  0.005]$ 
[P< O.05]$ 
* Mean titer of all positive reactions in miscellaneous controls tested was i or present in undiluted 
serum only. 
$ P values refer to difference from normal controls. 
TABL~ III 
Relationship of General Clinical Severity of Chorea to Result of Fluorescent Antibody 
Tests 
No. (+)/no.  tested  Titers 
Mild  2/13  Undiluted;  1:2 
Moderato  7/12  1:2; 1:2; 1:2; 1:2; 1:4; 1:8; 1:8 
Severe  5/5  1:2; h2; 1:4; 1:8; 1:16 
Rockefeller University Serum Bank were also tested in conjunction with sera 
from five patients serially followed in Egypt or Trinidad.  Evidence for temporal 
relationship  between  appearance of antibody and clinical  onset of chorea was 
present  in many patients.  It appeared that detectable  anti-neuronal  antibody 
was  associated  with  onset  of chorea  in  many  patients  but olden persisted for 
considerable periods of time (1-4 mo) after the subsidence of choreiform activity. 
A  representative series of serial studies are shown in Fig. 2. On the other hand 
several  instances  were  recorded  in  which  chorea  occurred  in  the  absence  of 
detectable antibody. In many of these latter cases the clinical episode of chorea 
represented a  mild attack or the first recorded in the patient. 
All  patients  with  positive  neuronal  cytoplasmic  fluorescence  and  carditis 1104  ANTI-NEURONAL  ANTIBODY  IN  CHOREA 
showed severe active carditis. No correlation was found between age or sex and 
positive reactions.  In addition,  no correlation was recorded with ASO titers. 
Studies of specificity.  Because of the previous studies indicating a  relation- 
ship between heart-reactive antibody and Group A streptococcal antigens,  var- 
ious absorption studies were carried out. Table IV indicates results of represent- 
ative data obtained after absorptions. Complete absorption of positive staining 
of neuronal cytoplasm was recorded in six of seven sera tested using 1 mg/ml of 
Group A Type 6 membranes.  By contrast,  no diminution in staining or absorp- 
tion  was recorded after absorption  of positive serum or serum dilutions  with 
Group D streptococcal membranes or cell walls. In Table IV it can be seen that 
no  absorption  was  noted  using  purified  Group  A  Type  6  carbohydrate  but 
moderate  diminution  of staining  was present  after absorption  with  Group A 
Type 6 cell walls.  These  latter  preparations,  however,  are  known  to  contain 
significant  amounts  of materials  derived  from  Group  A  membranes  (4).  No 
diminution  in positive staining was recorded after absorption with Cohn Frac- 
tion  IV.  In  addition  control  absorptions  using  both  Group  A  and  Group  D 
streptococcal antigens  did not abolish reactivity of control-positive ANA.  Ab- 
sorption of positive sera from patients with chorea using isolated neurons from 
human caudate nucleus produced complete disappearance of positive immuno- 
fluroescence, whereas absorptions using human or mouse liver did not result in 
detectable diminution of staining  (Table IV). Sonicated preparations of human 
cerebral cortex and mouse liver, as well as isolated caudate neurons did produce 
some  diminution  in  control  ANA  reactivity.  In  Table  V  are  shown  relative 
absorptive capacities of various streptococcal membrane and cell wall prepara- 
tions when used with four sera containing positive neuronal cytoplasmic anti- 
body reactivity.  All  sera  tested were adjusted by dilution  to give equivalent 
degrees of fluorescent staining of brain sections. Progressive loss of absorptive 
capacity was noted as lower concentrations  of Group A  membranes were em- 
ployed. Apparent equivalent reactivity in absorption was recorded using serum 
4154  from  a  patient  with  clinical  carditis  but  without  detectable  evidence of 
choreiform activity. 
An attempt was next made to test relative absorptive capacities of Group A 
streptococcal  membranes  derived from  a  pharyngeal  (T-12)  strain  and  those 
from a  higher  serotype (T-57)  isolated from skin sores of a  patient with acute 
glomerulonephritis.  Representative  results  of such  an  experiment  shown  in 
Table VI indicated that Type 12 membranes  were more effective in absorbing 
out anti-neuronal  antibody reactivity than those from a Type 57 strain.  Similar 
greater absorptive capacity was documented in some other positive sera when 
Types  11  and  12  were  compared  with  Types  55  and  57,  whereas  in  other 
individual  sera  equal  absorptive  capacity was  found when  membranes  from 
Types 6,  11, and 12 were compared with those from Types 55 and 57. 
In  view  of the  demonstrated  absorption  of neuron-reactive  antibodies  by 
various streptococcal membrane preparations,  it was of interest to determine 
whether  rabbit  antisera  made  against  purified  Group  A  streptococcal  mem- 
branes exhibited the same pattern of neuronal  staining.  No positive reactions 
were noted when three rabbit antisera to Group A Types 6 and 12 membranes 
were applied to fresh human brain caudate nucleus sections. Positive reactions 
were,  however,  recorded  concurrently  with  these same rabbit  antisera  using HUSBY,  van  de RIJN,  ZABItISKIE,  ABDIN~  AND  WILLIAMS  1105 
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FIG.  2.  (A) Serial studies of serum samples of a Rockefeller University patient before and 
after several clinical episodes of chorea. It can be seen that although weak anti-neuronal 
immunofluorescence was present without clinically manifest chorea on 2-17-53 and 4-19-53, 
the  subsequent clinical episodes  of chorea were  associated  with  a  rise in  titer of anti- 
neuronal  antibody  staining.  Antibody was  no  longer evident  7  wk  after subsidence of 
clinical chorea.  (B) Serial studies of Cairo patient 4138 show  presence of anti-neuronal 
antibody detected on admission,  12-21-75,  coincident with moderately severe chorea.  Be- 
sides aspirin therapy the patient also received phenobarbital and reserpine.  Subsequent 
subsidence of clinical chorea was associated with disappearance of detectable serum anti- 
neuronal antibody. A transient mild recurrence of chorea on 3-8-75 was not accompanied by 
the presence of detectable serum anti-neuronal antibody. 
human sarcolemmal preparations. In addition, sera strongly positive for human 
neuronal  cytoplasmic  fluorescence  were  not  absorbed  using preparations  of 
human sarcolemma at  1.0-0.01  mg/ml.  These data indicated that antigens in 
human sarcolemma and neuronal structures although both cross-reactive with 
streptococcal antigens were not identical. 
Discussion 
The present study demonstrates the presence of IgG antibodies in sera from 
children  with  rheumatic  fever  reacting  with  neuronal  cytoplasmic  antigens 
which appear to be preferentially increased in caudate and subthalamic nuclei 
of human brain.  A  higher proportion of sera  (46.6%) were positive in children 
with chorea than were recorded in those with active carditis (14.0%). In many 
instances there was a  direct correlation of positive fluorescent antibody reac- 1106  ANTI-NEURONAL  ANTIBODY  IN CHOREA 
TABLE  IV 
Results of  Absorption of Serum Showing Positive Immunofluorescent Reactions with Neuronal 
Cytoplasm in Caudate Nuclei using Streptococcal Antigens,  Tissue Homogenates,  and Cohn 
Unab- 
Reaction tested 
sorbed 
Caudate  nucleus  + 
neuron stain- 
ing 
Antinuclear  anti-  + + 
body 
Fraction IV 
Isol. 
Group A  Group A  Group A  Group D  neu-  Lyo- 
T6 mere-  T6 cell  T6 earbo-  mere-  Group D  rons  phil 
ceil wall  eau-  cere- 
brane  wall  hydrate  brahe  (A932)  date  bral 
(D471)  (D471)  (D471)  (A932)  nu-  cortex 
cleus 
0  ±  +  +  +  0  +  ~erum  298 (cho. 
tea) undiluted 
~erum W.W. 
(SLE)  1/50 
++  ++  ++  ++  ++  +  + 
Lyo-  Cohn 
phil  Fraction 
mouse  IV 
liver 
+  + 
+  ++ 
TABLE  V 
Absorption of  Four Sera from Children with Acute Rheumatic Fever using Membranes 
from  Group A  and Group D Streptococci  and Subsequent Immunofluorescence  of 
Neuronal Cytoplasm of Human Caudate Nuclei Neurons 
Serum 286 (cho-  Serum 274 (cho-  Serum 230 (cho-  Serum 4154  (car- 
Concentra-  rea)  rea)  rea)  ditis) 
tion of an- 
tigen used  Group  Group  Group  Group  Group  Group  Group  Group 
for absorp-  A T6  D mere-  A T6  D mem-  A T6  D T6  A T6  D  mem- 
tion  mem-  brane  mem-  brane  mem-  mem-  mem-  brane 
brahe  brane  brane  brane  brane 
mg/ml 
1  O*  +*  0  +  +_  +  0  + 
0.1  --  +  +--  +  +  +  +  + 
0.05  +  +  +  +  +  +  +  + 
* Refers to presence of positive staining of neurons in frozen sections of human caudate nucleus by 
serum after absorption. Staining with unabsorbed serum dilution positive (+) in all instances. 
tions with the  length  and  severity  of previous  chorea  attacks.  Reactivity  of 
antibodies for neuronal cytoplasmic constituents appeared to be higher in cau- 
date and subthalamic structures than in other brain tissue (cerebral cortex or 
medullary  nuclei)  containing  similar  high  proportions of neurons.  However, 
presence of moderate to weak staining in neuronal cytoplasm of cells in cerebral 
cortex  or  medullary  nuclei  indicated  that  the  reactive  structures  were  not 
localized only to the corpus striatum. 
Of particular importance were the absorption experiments which appeared to 
support the concept that staining of caudate and subthalamic neurons repre- 
sented cross-reactions between antigens present in Group A streptococcal mem- 
branes  and  neuronal  cytoplasm.  Clear-cut  absorption  using  Group  A  mem- 
branes and to a lesser extent cell walls in parallel with the absence of absorption 
with Group D streptococcal membranes or cell walls demonstrated specificity of 
Group A membrane-related antigens. In addition, positive immunofluorescence 
was completely removed using absorption with preparations of neurons from 
human caudate nucleus.  There was no correlation between positive neuronal HUSBY,  van  de RIJN,  ZABRISKIE,  ABDIN,  AND  WILLIAMS  1107 
TABLE  VI 
Comparative Absorptive Capacity ofT12 and T57 Group A Streptococcal Membranes for 
Absorption  of Anti-Neuronal Antibody 
Serunl  Dilution 
tested 
Group A streptococcus 
type 12" 
Group A streptococcus 
type 575 
Mem-  Mem- 
Cell walls  Cell walls 
branes (1  branes (1 
(1 mg/cc)  (1 mg/cc) 
mg/cc)  mg/cc) 
8088 (acute  Undiluted  +  +  +  + 
chorea)  1:2  0  +  +  + 
1:4  0  -+  0  + 
* Strain 12 represents original  isolate  from pharyax. 
5 Strain 57 isolated  from skin lesions  of  Trinidad patient with streptococcal  pyoderma and acute 
glomerulonephritis. 
staining and ANA. Furthermore, under immunofluroescence microscopy it was 
possible to differentiate peripheral neuronal cytoplasmic fluorescence from anti- 
nuclear reactions. The latter fluorescence was seen in virtually all sera from 
patients with systemic lupus erythematesus and in many sera from patients 
with  rheumatoid arthritis.  This  pattern  was  clearly differentiated from the 
globular homogeneous fluorescence seen  with  cytoplasmic neuronal  staining 
(Table  IV).  As  a  further test  for specificity,  it  was  noted that  control  sera 
obtained from normal Egyptian children and adults living in the same environ- 
ment as well as a separate group of normal adults showed a low incidence (1/55) 
of positive reactions. Similar results were obtained in a large number of miscel- 
laneous sera obtained from a wide variety of disease controls including subjects 
with widespread heterogeneous neurological lesions as  in multiple sclerosis, 
Parkinson's disease, or cerebral infarctions. It was difficult to establish a direct 
or complete correlation between cytoplasmic neuron staining and chorea since 
14.0%  of children with  active  carditis  alone,  who had never had  detectable 
chorea, also showed weak but definite staining reactions. It seems likely that 
neuronal cytoplasmic staining in this group of patients  represents the same 
general specificity of antibody since abolition of staining was also accomplished 
by absorption with Group A Type 6 streptococcal membranes (Table V). Serial 
studies  of sera  from children during  and  before  onset  of chorea  using  the 
streptococcal bank sera stored in some instances for 30 yr provided evidence for 
temporal relationship of antibody activity to chorea attacks. More recent serial 
sera obtained from patients  studied both in Egypt and Trinidad also showed 
disappearance  of antibody aider subsidence of chorea.  There were,  however, 
several instances of clear-cut acute chorea in which serial sera were studied 
where no anti-neuronal antibody was detected. In all of these individuals the 
clinical chorea episode recorded was either mild or the first clinically detected in 
that  particular  patient.  It  seems possible  that  studies  of the  anti-neuronal 
antibody in serial cerebrospinal fluid samples might provide insight into situa- 
tions  where chorea is  present but  serum antibodies  are undetectable using 
indirect immunofluorescence  techniques. Indeed the situation may be analogous 
to that previously documented in measles encephalitis or subacute sclerosing 1108  ANTI-NEURONAL  ANTIBODY  IN  CHOREA 
panencephalitis where discrepant results between detectable serum and cere- 
brospinal fluid antibody have been attributed to primary production of certain 
oligoclonal antibodies within the central nervous system (18). In addition since 
clinical  signs  of chorea are  often extremely subtle  and  rapidly masked by 
therapy such as that with phenobarbital or reserpine, complete correlation of 
clinical activity and presence of antibody may prove difficult. Studies are now in 
progress to assay cerebrospinal fluid and serum for presence of anti-neuronal 
antibody. If antibody to basal ganglia neurons were the primary cause of the 
chorea syndrome, then it is difficult to reconcile the occurrence of the antibody 
in sera from children with carditis who are known on clinical grounds never to 
have exhibited detectable chorea. 
The positive-staining reactions recorded with neurons in medullary centers 
such  as  hypoglossal nuclei or trigeminal nuclei indicate that  the  neuronal 
distribution of antigen is not unique to the caudate, subthalamic, or substantia 
nigra system. It is conceivable that IgG antibody to cytoplasmic structures in 
subthalamic and caudate nuclei is somehow involved in the genesis of chorea 
but that the clinical syndrome itself is modulated by other factors than merely 
the presence of antibody itself. Thus, extracellular streptococcal products, ge- 
netic background, or other parallel features may also be involved. 
The higher titers recorded in sera from children with chorea as compared to 
those with carditis coupled with the clear correlation of positive reactions with 
duration and clinical severity of chorea point to a significant relationship of the 
antibody  and  the  disease  process.  The  precise nature  of the  cross-reacting 
antigens in caudate and subthalamic nuclei and Group A streptococci remains 
unknown.  There  is  some experimental evidence, however, that  the  central 
nervous system structures involved in the pathogenesis of some forms of chorea 
may depend on alterations in catecholamines-  specifically, dopamine or norepi- 
nephrine (19, 20). Precise chemical definition of the basis of the positive immu- 
nofluorescent reactions described here must await further study. 
A recent report by Kingston and Glynn (21) presents findings which are in 
some  ways similar  to  the  approach outlined in  this  paper;  however, these 
authors recorded what  appeared to  be  cross-reactions between streptococcal 
antigens and limiting brain membrane, ependymal tissue, and fibrous astro- 
cytes. Rabbit antisera made against streptococci showed reactions with these 
neural structures in their hands. No such cross-reactions have yet been noted 
during our studies. It may be that a spectrum of antigens is present in neural 
tissues which cross-react with streptococcal materials. The precise relationship 
to clinical phenomena such as chorea remains unclear. 
Many features of Sydenham's chorea still  remain poorly defined and the 
chorea syndrome has always stood out as an enigmatic but clear manifestation 
of rheumatic activity. During our studies in Egypt, it appeared that the inci- 
dence of chorea was higher than that observed in other parts of the world where 
acute rheumatic fever is still clinically prevalent, such as India (22). While other 
factors may be operative, it is possible that the occurrence  of chorea itself  may be 
conditioned or somehow modulated by Ir genes related to HL-A phenotype. Such 
a  situation might explain the presence of subthalamic and caudate nuclear 
cytoplasmic antibodies in both chorea and active carditis. HUSBY,  van de RIJN,  ZABRISKIE,  ABDIN,  AND  WILLIAMS  1109 
Summary 
46%  of sera from 30  children with rheumatic chorea showed IgG antibody 
reacting with neuronal cytoplasm of human caudate and subthalamic nuclei. 
The antibody was  also detected in  14%  of 50  children with active rheumatic 
carditis. 55 normal control sera, as well as 148 sera from a broad variety of  other 
disease  states  showed  a  low  prevalence  (1.8-4.0%)  of positive  reactions.  In 
rheumatic chorea the presence of anti-neuronal antibody appeared to correlate 
with severity and duration of clinical attacks. Antibody reacting with neuronal 
cytoplasm was completely removed by absorption with Group A  streptococcal 
membranes  or  with  isolated human  neurons  from  caudate  nucleus.  Partial 
absorption of antibody was also recorded using Group A  cell wall preparations 
but not with Group A carbohydrate. No absorption of  positive reactions was seen 
with streptococcal Group D membranes or cell walls. In rheumatic chorea, anti- 
neuronal antibody appeared to represent cross-reaction with antigens shared by 
Group A  streptococcal membranes. 
The authors are indebted to Ms. K. Kilpatrick for invaluable expert laboratory assistance, and to 
Ms. B. Marquez and Ms. V. Starr for patient help with the manuscript. 
Received for publication 19 May 1976. 
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